524661

Welcure Drugs & Pharmaceuticals Share PriceWelcure Drugs & Pharmaceuticals

₹3.89
As on 22 September, 2023 | 08:05 BSE: 524661 NSE: WELCUREISIN: INE331C01017

Welcure Drugs & Pharmaceuticals Performance

Day Range

  • Low
  • High
3.89

52 Week Range

  • Low
  • High
3.89
  • Open Price
  • Previous Close
  • Volume

Start SIP in Welcure Drugs & Pharmaceuticals

Start SIP

Welcure Drugs & Pharmaceuticals Share Price

  • Over 1 Month 2.64%
  • Over 3 Month -5.12%
  • Over 6 Month -0.51%
  • Over 1 Year -59.14%

Welcure Drugs & Pharmaceuticals Key Statistics

Welcure Drugs & Pharmaceuticals Investment Rating

  • Master Rating:
  • Welcure Drugs & Pharms. has an operating revenue of Rs. 0.17 Cr. on a trailing 12-month basis. An annual revenue growth of 118% is outstanding, Pre-tax margin of 0% needs improvement, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. From an O'Neil Methodology perspective, the stock has an EPS Rank of 53 which is a POOR score indicating inconsistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 97 indicates it belongs to a poor industry group of Medical-Biomed/Biotech and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Welcure Drugs & Pharmaceuticals Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 000000
Operating Expenses Qtr Cr 000000
Operating Profit Qtr Cr 000000
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr 000000
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 00
Operating Expenses Annual Cr 00
Operating Profit Annual in Cr 00
Depreciation Cr 00
Interest Annual Cr 00
Tax Annual Cr 00
Net Profit Annual Cr 00
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 0
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 20
Fixed Assets Annual Cr 00
Total Non Current Assets Annual Cr 20
Total Current Assets Annual Cr 00
Total Assets Annual Cr 20
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 10
ROE Annual % 725
ROCE Annual % 725
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 022
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Welcure Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹3.89
0 (0%)
  • Bullish Moving Average
  • ___
  • 11
  • Bearish Moving Average
  • ___
  • 5
  • 20 Day
  • ₹3.83
  • 50 Day
  • ₹3.85
  • 100 Day
  • ₹4
  • 200 Day
  • ₹4.52
  • 20 Day
  • ₹3.83
  • 50 Day
  • ₹3.82
  • 100 Day
  • ₹3.9
  • 200 Day
  • ₹4.31

Welcure Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹3.89
Resistance
First Resistance ₹3.89
Second Resistance ₹3.89
Third Resistance ₹3.89
RSI 54.32
MFI 38.21
MACD 0.01
Support
First Resistance ₹3.89
Second Resistance ₹3.89
Third Resistance ₹3.89

Welcure Drugs & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 14,314 1,417,372 99.02
Week 17,157 1,692,220 98.63
1 Month 36,207 3,094,983 85.48
6 Month 34,196 2,750,074 80.42

Welcure Drugs & Pharmaceuticals Result Highlights

Welcure Drugs & Pharmaceuticals Synopsis

BSE-Medical-Biomed/Biotech

Welcure Drugs & is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 13.44 Cr. for the Year ended 31/03/2023. Welcure Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/08/1996 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L24232DL1996PLC227773 and registration number is 227773.
Market Cap 5
Sales
Shares in Float 1.35
No of funds 1
Yield
Book Value 3.44
U/D Vol ratio 0.9
LTDebt / Equity
Alpha -0.34
Beta 0.43

Welcure Drugs & Pharmaceuticals

Owner NameJun-23Mar-23Dec-22Sep-22
Promoters
Financial Institutions/ Banks 0.01%0.01%0.01%
Individual Investors 93.67%93.65%93.73%88.34%
Others 6.33%6.34%6.26%11.65%

Welcure Drugs & Pharmaceuticals Management

Name Designation
Mr. Dharam Chand Jain Non Executive Director
Mr. Murari Lal Bhateja Independent Director
Mr. Gagan Juneja Independent Director
Ms. Mitashi Bisaria Non Executive Director
Mr. Mayank Bhandari Ind. Non-Executive Director
Mr. Vishal Mehra Chairman & Managing Director

Welcure Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Welcure Drugs & Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-08-14 Quarterly Results
2023-07-11 Quarterly Results
2023-05-29 Audited Results
2023-02-14 Quarterly Results (Revised)
2022-11-29 Preferential issue of shares
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Welcure Drugs & Pharmaceuticals FAQs

What is Share Price of Welcure Drugs & Pharmaceuticals ?

Welcure Drugs & Pharmaceuticals share price is ₹3 As on 22 September, 2023 | 07:51

What is the Market Cap of Welcure Drugs & Pharmaceuticals ?

The Market Cap of Welcure Drugs & Pharmaceuticals is ₹5.3 Cr As on 22 September, 2023 | 07:51

What is the P/E ratio of Welcure Drugs & Pharmaceuticals ?

The P/E ratio of Welcure Drugs & Pharmaceuticals is 42 As on 22 September, 2023 | 07:51

What is the PB ratio of Welcure Drugs & Pharmaceuticals ?

The PB ratio of Welcure Drugs & Pharmaceuticals is 3.5 As on 22 September, 2023 | 07:51

Q2FY23